Internationaler Online-Medizinrat (IOMC) | Medizinische Forschung

GET THE APP

Abstrahiert/indiziert in

Open J Gate, Genamik, Google Gelehrte, ISA (Indische wissenschaftliche Zusammenfassungen), CAS Datenbank (Chemische abstrakte Dienstleistungen), CABI (UK), Index Copernicus, Hinari, EBSCO, Ulrich's Periodicals Directory, Botanical Pesticides, Weed Abstracts, AgBiotechNet, VetMed Ressource , Abstracts zur Pflanzenphysiologie, Abstracts zur Agroforstwirtschaft, Abstracts zur Helminthologie, Ziergartenbau, Abstracts zu pflanzengenetischen Ressourcen, Nachrichten und Informationen zu Schweinen, Abstracts zur Milchwissenschaft, Datenbank für Agrarökonomie, Datenbank zur Parasitologie, CAB-Abstracts, Zoologische Aufzeichnungen, Nachrichten und Informationen nach der Ernte, Ernährungs- und Lebensmittelwissenschaften Datenbank, Organische Forschung Datenbank, Globale Gesundheit, ABC Chemie,Wissenschaftszentrale und SCIMAGO sind in der Bearbeitung vieler weiterer.

Zusammenfassung mit Mehrwert

Laboratory of Neurodegenerative Diseases

Research in Dementia in Greece

Research, as we all know is the only way for new Knowledge. We have run many research projects in Greece. the recent ones in order to find new collaborators for future applicati..Mehr sehen»

Forschung

Reformulation-Focused Life Cycle Management of the FDA-Approved Drugs

Kalyana C Venneti, Rohit S Nalavade, Sidharth Shankar Jha, Subramanian Akshay, Tulika Jaokar, Nandu Gattu, Sanjeev Kumar Shangary*

Drug Life Cycle Management (LCM) includes a variety of strategies that are implemented by biotech and pharmaceutical companies to uncover the hidden value of the drug and maximi..Mehr sehen»

Rezensionsartikel

Does Spasticity Reduction by Botulinum Toxin Type A Improve Upper Limb Functionality in Adult Post-Stroke Patients? A Systematic Review of Relevant Studies

Domenico Intiso, Valentina Simone, Filomena Di Rienzo, Andrea Santamato, Mario Russo, Maurizio Tolfa and Mario Basciani

Objective: Botulinum toxin type A (BTX-A) use reduces upper limb (UL) spasticity in stroke patients, but the effects
on functional recovery remain uncertain. The aim of p..Mehr sehen»

Forschungsartikel

Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting

Totaro R, Costantino G, Bellantonio P, Danni M, Carmine CD, Fantozzi R, Cerqua R, Fuiani A, Carrocci C, Mundi C, Ruggieri S, Marini C, Provinciali L and Carolei A

Objective: The aim of this study was to compare the efficacy of natalizumab and fingolimod in relapsing-remitting multiple sclerosis patients in rea..Mehr sehen»